RXRX · Recursion Pharmaceuticals, Inc. · Documents
$3.63
-0.03 (-0.82%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.96B
Shares
535.34M
Volume · Oct 21
19.32M
Avg daily vol (3M)
21.71M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEFM14A | — | 2024-10-10 | — | |
| 8-K | — | 2024-10-02 | — | |
| DEFA14A | — | 2024-09-19 | — | |
| PREM14A | — | 2024-09-17 | — | |
| DEFA14A | — | 2024-09-04 | — | |
| DEFA14A | — | 2024-09-03 | — | |
| 8-K | — | 2024-09-03 | — | |
| DEFA14A | — | 2024-08-28 | — | |
| 8-K | — | 2024-08-28 | — | |
| DEFA14A | — | 2024-08-09 | — | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| DEFA14A | — | 2024-08-08 | — | |
| DEFA14A | — | 2024-08-08 | — | |
| 8-K | — | 2024-08-08 | 2024-08-06 | |
| 8-K | — | 2024-08-06 | — | |
| 8-K | — | 2024-06-27 | 2024-06-26 | |
| 8-K | — | 2024-06-24 | — | |
| 8-K | — | 2024-06-07 | 2024-06-03 | |
| 8-K | — | 2024-05-24 | 2024-05-21 | |
| DEFA14A | — | 2024-05-24 | — | |
| 8-K | — | 2024-05-09 | 2024-05-07 | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| DEFA14A | — | 2024-04-23 | — | |
| DEF 14A | — | 2024-04-23 | 2024-06-03 | |
| 8-K | — | 2024-04-16 | 2024-04-15 | |
| 10-K | — | 2024-02-29 | 2023-12-31 | |
| 8-K | — | 2024-02-27 | — | |
| 8-K | — | 2024-02-07 | 2024-02-06 | |
| 8-K | — | 2024-01-31 | 2024-01-25 | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-20 | — | |
| 8-K | — | 2023-12-15 | — | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-10-02 | 2023-09-28 | |
| 8-K | — | 2023-09-05 | — | |
| 8-K/A | — | 2023-08-11 | 2023-06-16 | |
| 8-K | — | 2023-08-08 | — | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-07-12 | 2023-07-11 | |
| 8-K | — | 2023-06-20 | 2023-06-16 | |
| 8-K | — | 2023-06-13 | — | |
| 8-K | — | 2023-06-09 | — | |
| S-3ASR | — | 2023-05-30 | — | |
| 8-K | — | 2023-05-25 | — | |
| 8-K | — | 2023-05-17 | 2023-05-16 | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| 8-K | — | 2023-05-08 | — | |
| 8-K | — | 2023-05-08 | — | |
| DEFA14A | — | 2023-04-28 | — |
Showing 51–100 of 140 filings
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
39 filings
39 filers
Visit website
Investor relations